{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:01:04Z","timestamp":1781715664510,"version":"3.54.5"},"reference-count":93,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.hfc.2026.02.006","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:58:36Z","timestamp":1781711916000},"page":"301-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Interplay of Heart Failure and Pulmonary Embolism"],"prefix":"10.1016","volume":"22","author":[{"given":"Mariam","family":"Farid-Zahran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"M\u00e9ndez-Bail\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Demelo-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hfc.2026.02.006_bib1","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S2352-3026(15)00228-8","article-title":"Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis","volume":"3","author":"Tang","year":"2016","journal-title":"Lancet Haematol"},{"issue":"7","key":"10.1016\/j.hfc.2026.02.006_bib2","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/j.1538-7836.2005.01458.x","article-title":"The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism","volume":"3","author":"Di Minno","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.hfc.2026.02.006_bib3","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.ijcard.2012.12.018","article-title":"Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges","volume":"167","author":"Zannad","year":"2013","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2026.02.006_bib4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11897-016-0308-6","article-title":"Coagulation abnormalities in heart failure: pathophysiology and therapeutic implications","volume":"13","author":"Kim","year":"2016","journal-title":"Curr Heart Fail Rep"},{"issue":"6","key":"10.1016\/j.hfc.2026.02.006_bib5","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1002\/ehf2.13015","article-title":"Predictive value of heart failure with reduced versus preserved ejection fraction for outcome in pulmonary embolism","volume":"7","author":"Obradovic","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hfc.2026.02.006_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.amjcard.2023.03.003","article-title":"Impact of chronic heart failure on acute pulmonary embolism in-Hospital outcomes (from a contemporary study)","volume":"195","author":"Quintero-Martinez","year":"2023","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.006_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53641-0","article-title":"Risk of venous thromboembolism after new onset heart failure","volume":"9","author":"Smilowitz","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.hfc.2026.02.006_bib8","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1378\/chest.06-2077","article-title":"Acute pulmonary embolism is an independent predictor of adverse events in severe decompensated heart failure patients","volume":"131","author":"Darze","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.006_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCHEARTFAILURE.109.892349","article-title":"Venous thromboembolism in hospitalized patients with heart failure: incidence, prognosis, and prevention","volume":"3","author":"Ng","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.006_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/eurjhf\/hfs171","article-title":"Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm","volume":"15","author":"Hopper","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.006_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jchf.2021.01.009","article-title":"Thromboembolism in heart failure patients in sinus rhythm","volume":"9","author":"Lin","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"12","key":"10.1016\/j.hfc.2026.02.006_bib12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1160\/TH12-08-0578","article-title":"Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis","volume":"108","author":"Lip","year":"2012","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.hfc.2026.02.006_bib13","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1164\/rccm.200506-862OC","article-title":"Derivation and validation of a prognostic model for pulmonary embolism","volume":"172","author":"Aujesky","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hfc.2026.02.006_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejim.2015.12.010","article-title":"A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)","volume":"29","author":"Franco Moreno","year":"2016","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.hfc.2026.02.006_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-Year risk of major bleeding in patients with atrial fibrillation","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"issue":"15","key":"10.1016\/j.hfc.2026.02.006_bib16","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/archinternmed.2010.199","article-title":"Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism","volume":"170","author":"Jim\u00e9nez","year":"2010","journal-title":"Arch Intern Med"},{"issue":"13","key":"10.1016\/j.hfc.2026.02.006_bib17","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.107.726232","article-title":"Clinical Predictors for Fatal Pulmonary Embolism in 15 520 Patients With Venous Thromboembolism: findings From the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry","volume":"117","author":"Laporte","year":"2008","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.006_bib18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjmed.2010.10.014","article-title":"Venous thromboembolism in heart failure: preventable deaths during and after hospitalization","volume":"124","author":"Piazza","year":"2011","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.hfc.2026.02.006_bib19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/CIRCULATIONAHA.113.003126","article-title":"Predicting the risk of venous thromboembolism in patients hospitalized with heart failure","volume":"130","author":"Mebazaa","year":"2014","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.hfc.2026.02.006_bib20","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"10.1016\/j.hfc.2026.02.006_bib21","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.hfc.2026.02.006_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/archinte.1977.03630170075017","article-title":"Heart failure: a proposed definition and classification","volume":"137","author":"Wagner","year":"1977","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.hfc.2026.02.006_bib23","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/oxfordjournals.eurheartj.a061500","article-title":"The defintion of heart failure","volume":"4","author":"Denolin","year":"1983","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.006_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","article-title":"Universal definition and classification of heart failure","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"issue":"10159","key":"10.1016\/j.hfc.2026.02.006_bib25","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.hfc.2026.02.006_bib26","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa1406656","article-title":"Demographic and epidemiologic drivers of global cardiovascular mortality","volume":"372","author":"Roth","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.006_bib27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ejhf.483","article-title":"Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review: prevalence of heart failure and ventricular dysfunction","volume":"18","author":"van Riet","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"10.1016\/j.hfc.2026.02.006_bib28","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hfc.2026.02.006_bib29","first-page":"1858","article-title":"Epidemiology of heart failure","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"10.1016\/j.hfc.2026.02.006_bib30","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/ejhf.1594","article-title":"Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis","volume":"21","author":"Jones","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.hfc.2026.02.006_bib31","doi-asserted-by":"crossref","first-page":"e406","DOI":"10.1016\/S2468-2667(19)30108-2","article-title":"20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study","volume":"4","author":"Lawson","year":"2019","journal-title":"Lancet Public Health"},{"issue":"6","key":"10.1016\/j.hfc.2026.02.006_bib32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjcard.2006.03.064","article-title":"Risk of venous thromboembolism in patients hospitalized with heart failure","volume":"98","author":"Beemath","year":"2006","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.hfc.2026.02.006_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025342","article-title":"Incidence and prognostic implications of readmissions caused by thrombotic events after a heart failure hospitalization","volume":"11","author":"Chaudhury","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"10.1016\/j.hfc.2026.02.006_bib34","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.111.025627","article-title":"Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis","volume":"124","author":"S\u00f8rensen","year":"2011","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.hfc.2026.02.006_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000173724","article-title":"Venous thromboembolism prevention in patients with heart failure: an often neglected issue","volume":"36","author":"Imberti","year":"2007","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"2","key":"10.1016\/j.hfc.2026.02.006_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacc.2019.10.058","article-title":"Incident heart failure and long-term risk for venous thromboembolism","volume":"75","author":"Fanola","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.006_bib37","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1378\/chest.06-2993","article-title":"Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients","volume":"132","author":"Tapson","year":"2007","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.hfc.2026.02.006_bib38","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.amjcard.2006.05.030","article-title":"Pulmonary embolism as a cause of death in adults who died with heart failure","volume":"98","author":"Beemath","year":"2006","journal-title":"Am J Cardiol"},{"issue":"8","key":"10.1016\/j.hfc.2026.02.006_bib39","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0895-4356(00)00373-5","article-title":"Congestive heart failure and outpatient risk of venous thromboembolism A retrospective, case-control study","volume":"54","author":"Howell","year":"2001","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"10.1016\/j.hfc.2026.02.006_bib40","doi-asserted-by":"crossref","first-page":"512","DOI":"10.2174\/1381612827666210830102419","article-title":"Venous thromboembolism in patients with heart failure","volume":"28","author":"Bechlioulis","year":"2022","journal-title":"Curr Pharm Des"},{"issue":"22","key":"10.1016\/j.hfc.2026.02.006_bib41","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1001\/archinte.160.22.3415","article-title":"An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study","volume":"160","author":"Samama","year":"2000","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.hfc.2026.02.006_bib42","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/archinte.164.9.963","article-title":"Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX study","volume":"164","author":"Alikhan","year":"2004","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.006_bib43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.hfc.2026.02.006_bib44","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/jth.13336","article-title":"Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH","volume":"14","author":"Kearon","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"05","key":"10.1016\/j.hfc.2026.02.006_bib45","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1160\/TH11-09-0611","article-title":"Infections and inflammatory diseases as risk factors for venous thrombosis: a systematic review","volume":"107","author":"Tichelaar","year":"2012","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.hfc.2026.02.006_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2019.11.028","article-title":"Venous thromboembolism in heart failure patients","volume":"75","author":"Goldhaber","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.006_bib47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cardfail.2022.12.012","article-title":"Blood coagulation disorders in heart failure: from basic science to clinical perspectives","volume":"29","author":"Siniarski","year":"2023","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.006_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2013.07.007","article-title":"Antiplatelet and anticoagulant agents in heart failure","volume":"2","author":"Gurbel","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"16","key":"10.1016\/j.hfc.2026.02.006_bib49","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","article-title":"Endothelial dysfunction, arterial stiffness, and heart failure","volume":"60","author":"Marti","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.006_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/jclinpath-2015-203172","article-title":"Tissue factor is unregulated in microvascular endothelial cells of patients with heart failure","volume":"69","author":"Reichman-Warmusz","year":"2016","journal-title":"J Clin Pathol"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.006_bib51","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0002-8703(94)90670-X","article-title":"Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure","volume":"127","author":"Sbarouni","year":"1994","journal-title":"Am Heart J"},{"issue":"22","key":"10.1016\/j.hfc.2026.02.006_bib52","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/eurheartj\/ehl305","article-title":"Platelets and heart failure","volume":"27","author":"Chung","year":"2006","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.006_bib53","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ejhf.2003","article-title":"Plasma D -dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF trial","volume":"23","author":"Ferreira","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"10.1016\/j.hfc.2026.02.006_bib54","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1161\/CIRCULATIONAHA.106.661397","article-title":"Risk of thromboembolism in heart failure: an analysis from the sudden cardiac death in heart failure trial (SCD-HeFT)","volume":"115","author":"Freudenberger","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2026.02.006_bib55","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2012.04.002","article-title":"Thrombotic biomarkers and left ventricle characteristics as short-term predictors of thrombotic events in patients hospitalized for acute decompensated heart failure","volume":"23","author":"Aispuru","year":"2012","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.hfc.2026.02.006_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1358863X07079017","article-title":"Thromboprophylaxis with dalteparin in medical patients: which patients benefit?","volume":"12","author":"Cohen","year":"2007","journal-title":"Vasc Med"},{"issue":"7537","key":"10.1016\/j.hfc.2026.02.006_bib57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial","volume":"332","author":"Cohen","year":"2006","journal-title":"BMJ. de"},{"issue":"12","key":"10.1016\/j.hfc.2026.02.006_bib58","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0002-9149(00)01481-8","article-title":"Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in medical patients with enoxaparin (MEDENOX) trial","volume":"86","author":"Turpie","year":"2000","journal-title":"Am J Cardiol"},{"issue":"22","key":"10.1016\/j.hfc.2026.02.006_bib59","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1182\/bloodadvances.2018022954","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients","volume":"2","author":"Sch\u00fcnemann","year":"2018","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.hfc.2026.02.006_bib60","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.006_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11239-006-7732-5","article-title":"Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study","volume":"22","author":"Hull","year":"2006","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.006_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002797","article-title":"Extended prophylaxis for venous thromboembolism after hospitalization for medical illness: a trial sequential and cumulative meta-analysis. Cannegieter SC","volume":"16","author":"Bajaj","year":"2019","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.hfc.2026.02.006_bib63","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1056\/NEJMoa1601747","article-title":"Extended thromboprophylaxis with Betrixaban in acutely ill medical patients","volume":"375","author":"Cohen","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.hfc.2026.02.006_bib64","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1111096","article-title":"Rivaroxaban for thromboprophylaxis in acutely ill medical patients","volume":"368","author":"Cohen","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.hfc.2026.02.006_bib65","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMoa1805090","article-title":"Rivaroxaban for thromboprophylaxis after hospitalization for medical illness","volume":"379","author":"Spyropoulos","year":"2018","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.hfc.2026.02.006_bib66","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa1700518","article-title":"Rivaroxaban or aspirin for extended treatment of venous thromboembolism","volume":"376","author":"Weitz","year":"2017","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.hfc.2026.02.006_bib67","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.hfc.2026.02.006_bib68","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMoa2509426","article-title":"Apixaban for extended treatment of provoked venous thromboembolism","volume":"393","author":"Piazza","year":"2025","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.hfc.2026.02.006_bib69","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.amjmed.2005.11.035","article-title":"Pulmonary embolism in patients with chronic obstructive pulmonary disease or congestive heart failure","volume":"119","author":"Monreal","year":"2006","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.hfc.2026.02.006_bib70","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.amjcard.2007.11.051","article-title":"Heart failure in patients with deep vein thrombosis","volume":"101","author":"Piazza","year":"2008","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.hfc.2026.02.006_bib71","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5603\/CJ.2012.0115","article-title":"The influence of acute pulmonary embolism on early and delayed prognosis for patients with chronic heart failure","volume":"19","author":"Gromadzi\u0144ski","year":"2012","journal-title":"Cardiol J"},{"issue":"4","key":"10.1016\/j.hfc.2026.02.006_bib72","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1378\/chest.128.4.2576","article-title":"Incidence and clinical predictors of pulmonary embolism in severe heart failure patients admitted to a coronary care unit","volume":"128","author":"Darze","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.hfc.2026.02.006_bib73","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.carpath.2018.04.004","article-title":"Thromboembolic findings in patients with heart failure at autopsy","volume":"35","author":"de Macedo","year":"2018","journal-title":"Cardiovasc Pathol"},{"issue":"08","key":"10.1016\/j.hfc.2026.02.006_bib74","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1160\/TH11-12-0901","article-title":"NT-pro-BNP levels in patients with acute pulmonary embolism are correlated to right but not left ventricular volume and function","volume":"108","author":"Pasha","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hfc.2026.02.006_bib75","doi-asserted-by":"crossref","unstructured":"Salah K, Stienen S, Pinto YM, et al. Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction, Heart, 105 (15),2019, 1182-1189.","DOI":"10.1136\/heartjnl-2018-314173"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.006_bib76","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1054\/jcaf.2002.125368","article-title":"The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure","volume":"8","author":"Lee","year":"2002","journal-title":"J Card Fail"},{"key":"10.1016\/j.hfc.2026.02.006_bib77","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cca.2014.12.027","article-title":"Cardiac troponin assays in the management of heart failure","volume":"441","author":"Torre","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.006_bib78","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1378\/chest.128.3.1836","article-title":"The acutely decompensated right ventricle","volume":"128","author":"Piazza","year":"2005","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hfc.2026.02.006_bib79","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3390\/jcm13051284","article-title":"Prognostic significance of heart failure in acute pulmonary embolism: a comprehensive assessment of 30-Day outcomes","volume":"13","author":"Farid-Zahran","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.hfc.2026.02.006_bib80","doi-asserted-by":"crossref","unstructured":"Maestre A, Trujillo-Santos J, Riera-Mestre A, et al. Identification of low-risk patients with acute symptomatic pulmonary embolism for outpatient therapy, Ann Am Thorac Soc, 12 (8),2015, 1122-1129.","DOI":"10.1513\/AnnalsATS.201504-202OC"},{"issue":"07","key":"10.1016\/j.hfc.2026.02.006_bib81","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1160\/TH08-03-0193","article-title":"Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE registry","volume":"100","author":"Ru\u00edz-Gim\u00e9nez","year":"2008","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.006_bib82","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/jth.14691","article-title":"Validation of the VTE-BLEED score\u2019s long-term performance for major bleeding in patients with venous thromboembolisms: from the COMMAND VTE registry","volume":"18","author":"Nishimoto","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.hfc.2026.02.006_bib83","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/rth2.12214","article-title":"Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism","volume":"3","author":"Klok","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"10.1016\/j.hfc.2026.02.006_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20120","article-title":"Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation","volume":"20","author":"Ensor","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.hfc.2026.02.006_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.j1065","article-title":"Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study","author":"Rodger","year":"2017","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.006_bib86","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000467","article-title":"D -dimer levels over time and the risk of recurrent venous thromboembolism: an update of the Vienna prediction model","volume":"3","author":"Eichinger","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.hfc.2026.02.006_bib87","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1111\/jth.13781","article-title":"External validation of the DASH prediction rule: a retrospective cohort study","volume":"15","author":"Tosetto","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.hfc.2026.02.006_bib88","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.medcli.2016.06.034","article-title":"Valor pron\u00f3stico del antecedente de insuficiencia cardiaca en pacientes ingresados con tromboembolia pulmonar","volume":"147","author":"Lozano-Cruz","year":"2016","journal-title":"Med Clin"},{"issue":"10","key":"10.1016\/j.hfc.2026.02.006_bib89","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehq021","article-title":"Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis","volume":"31","author":"Ducrocq","year":"2010","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.hfc.2026.02.006_bib90","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline Risk of major bleeding in Non\u2013ST-Segment\u2013Elevation myocardial infarction: the CRUSADE (can rapid risk stratification of unstable angina patients suppress ADverse outcomes with early implementation of the ACC\/AHA guidelines) bleeding score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.hfc.2026.02.006_bib91","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1253\/circj.CJ-21-0686","article-title":"Simplified academic research consortium for high bleeding risk (ARC-HBR) definition predicts bleeding events in patients with heart failure","volume":"86","author":"Sato","year":"2021","journal-title":"Circ J"},{"issue":"2","key":"10.1016\/j.hfc.2026.02.006_bib92","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11239-017-1519-8","article-title":"Effectiveness and safety of apixaban therapy in daily-care patients with atrial fibrillation: results from the dresden NOAC registry","volume":"44","author":"Helmert","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.hfc.2026.02.006_bib93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.thromres.2020.12.031","article-title":"Prediction models for recurrence and bleeding in patients with venous thromboembolism: a systematic review and critical appraisal","volume":"199","author":"De Winter","year":"2021","journal-title":"Thromb Res"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713626000176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713626000176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:59:29Z","timestamp":1781711969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713626000176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1551713626000176"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2026.02.006","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Interplay of Heart Failure and Pulmonary Embolism","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2026.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}